Syngene Intl
₹361
- Market Cap
- ₹15,517Cr.
- P/E Ratio
- 52.4
- P/B Ratio
- 3.01
- EPS (TTM)
- ₹6.89
- Div Yield
- 0.35%
- ROCE
- 9.99%
- ROE
- 7.78%
52W Low: ₹34452W High: ₹679
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 5.0% a year over three years.
- Debt is 0.09× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Syngene_Intl — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 52.4P/E: 52.4 | P/B: 3.01Growth
ModestSales CAGR — 3Y: 5% · 1Y: -3%Profitability
Low MarginROCE: 9.99% | ROE: 7.78%Key Metrics
Valuation
Price / Sales 4.31x
Price / FCF 28.4x
Book Value ₹120
Margins & returns
Operating Margin 22%
Net Margin 6.1%
Return on Assets 3.1%